PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rett Syndrome Research Trust awards $1.3 million for clinical trial

Award to Case Western Reserve, Cleveland Clinic follows creation of regional collaborative to advance research

2015-03-23
(Press-News.org) A surgical sedative may hold the key to reversing the devastating symptoms of a neurodevelopmental disorder found almost exclusively in females. Ketamine, used primarily for operative procedures, has shown such promise in mouse models that Case Western Reserve and Cleveland Clinic researchers soon will launch a two-year clinical trial using low doses of the medication in up to 35 individuals with Rett Syndrome.

The $1.3 million grant from Rett Syndrome Research Trust (RSRT) represents a landmark step in area researchers' efforts to create a true regional collaborative that capitalizes on the diverse expertise of scientists and clinicians all dedicated to improving the lives of individuals struck with this and other autism spectrum disorders. Katz and Thomas Frazier II, PhD, director of Cleveland Clinic Center for Autism, led creation of a Northeast Ohio consortium three years ago to encourage research partnerships among basic scientists and clinicians. Cleveland Clinic, University Hospitals and Case Western Reserve each contributed seed funding; the consortium also is affiliated with the university's International Center for Autism Research and Education.

Rett Syndrome, which occurs in roughly 1 of every 10,000 female births, leads to a constellation of symptoms mirroring those of autism, Parkinson's disease, cerebral palsy and anxiety disorders. Its presence does not appear until after birth; symptoms often do not begin to appear until the child reaches six months of age. Development slows, communication skills decline, and motor skills also are affected. The rate of growth of the head decreases, and seizures and/or disruptions in breathing patterns are common.

First identified in the 1960s, Rett Syndrome did not reach mainstream public awareness until the 1980s. In 1999, scientists at Baylor University identified the syndrome's cause - mutations of a gene called MECP2 on the X chromosome. This gene has more than 200 different mutations, however, and to date no cure has been found. Treatment generally focuses on managing the conditions that accompany the disorder.

Case Western Reserve neurosciences Professor David Katz had greater aspirations. A nationally renowned expert on Rett Syndrome, he built a case for testing ketamine in humans through intensive study of the medication's impact on mice. Using mice that were genetically engineered animals to model the human disease, they discovered that the mice showed imbalances in nerve cell activity among brain regions. In simplest terms, some areas evidenced too much, and some too little - differences that Katz believes play a central part in the neurological dysfunctions suffered by those with Rett Syndrome.

Enter ketamine, a medication already shown to have positive influence on some neuropsychiatric disorders, including severe depression and obsessive-compulsive behavior. After the mice received even low doses of the drug, their brain activity recalibrated to a more normal level. As a result, the mice showed improved neurological function as well.

"The effects were dramatic, and included complete reversal of some disease symptoms," Katz said.

The Rett Syndrome Research Trust, a Connecticut-based nonprofit, is the country's largest private funder of research dedicated to finding effective treatments, and eventually a cure, for the disorder. The trust's co-founder and executive director is Monica Coenraads, the mother of a teenage daughter with Rett syndrome.

"Dr. Katz's encouraging results with testing low-dose ketamine in mouse models of Rett Syndrome, coupled with anecdotes we have heard from parents whose children received ketamine during various procedures, convinced the RSRT and its scientific advisors that this was a path we needed to explore aggressively," Coenraads said.

The trial will focus primarily on measuring changes within breathing patterns and the overall clinical severity of the patients' conditions. Each participant will receive a placebo as well as different doses of ketamine in a random order. Each session will take place over two study days, separated by at least a month. Throughout the trial, investigators will monitor and record each participant's breathing and behavioral symptoms. By comparing responses across the study sessions, the investigators will be able to determine whether ketamine is effective - and, if so, which dose is best.

Katz emphasized that the doses involved in this trial are significantly lower than those involved in ketamine's use as anesthesia. The drug's name may be familiar to some because of its popularity as a "club drug" for illicit recreational use starting in the 1970s. The amount of ketamine used for these illegal purposes is dramatically higher than the doses that will be administered in the Rett trial.

Collaborating with Katz is co-principal investigator Daniel I. Sessler, MD, the Michael Cudahy Professor and Chair of the Department of Outcomes Research at the Cleveland Clinic and professor of anesthesiology at Case Western Reserve, and Frazier, also an assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve.

"Designing a clinical trial for Rett Syndrome is a challenge," Coenraads added. "I was very impressed with the seriousness and thoughtfulness on the part of Drs. Katz, Sessler and Frazier throughout the protocol development process."

If the upcoming low-dose ketamine clinical trial proves successful, a next step will be to test whether the drug can be administered on an ongoing basis.

"Because ketamine was initially developed for use in surgical anesthesia, it has never been used to treat a chronic illness," Katz said. "So one of the next questions will be whether we can develop a chronic dosing paradigm with this or similar drugs that would be safe and effective for patients with Rett syndrome."

Katz, whose research secured the trial, is one of the leading authorities on the basic science of Rett syndrome and development of potential therapies. Sessler, a pediatrician and anesthesiologist by specialty, is an expert not only in conducting clinical trials, but also in the safe administration of sedative and anesthetic drugs. Frazier has extensive experience in clinical research on autism spectrum disorders, including drug trials. Other key co-investigators in the trial include Sumit Parikh, MD, director of Cleveland Clinic Neurogenetics, Metabolic and Mitochondrial Disease Program, and Edward J. Mascha, PhD, senior biostatistician in the Department of Outcomes Research at Cleveland Clinic.

INFORMATION:

About Case Western Reserve University School of Medicine Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.

Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research-oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."

The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu



ELSE PRESS RELEASES FROM THIS DATE:

3-D satellite, GPS earthquake maps isolate impacts in real time

3-D satellite, GPS earthquake maps isolate impacts in real time
2015-03-23
When an earthquake hits, the faster first responders can get to an impacted area, the more likely infrastructure--and lives--can be saved. New research from the University of Iowa, along with the United States Geological Survey (USGS), shows that GPS and satellite data can be used in a real-time, coordinated effort to fully characterize a fault line within 24 hours of an earthquake, ensuring that aid is delivered faster and more accurately than ever before. Earth and Environmental Sciences assistant professor William Barnhart used GPS and satellite measurements from ...

Along with antiretroviral medications, doctors may prescribe exercise for people with HIV

2015-03-23
In addition to antiretroviral medications, people with HIV may soon begin receiving a home exercise plan from their doctors, according to a researcher at Case Western Reserve University's Frances Payne Bolton School of Nursing. "People with HIV are developing secondary chronic illnesses earlier and more frequently than their non-HIV counterparts," said Allison Webel, PhD, RN, assistant professor of nursing. "And heart disease is one for which they are especially at risk." An estimated 1.2 million people nationally live with HIV, according to the Centers for Disease ...

Highlights from the inaugural issue of ACS Central Science

2015-03-23
Today, ACS is launching its first open access multidisciplinary research journal. Aspiring to communicate the most novel and impactful science developments, ACS Central Science will feature peer-reviewed articles reporting on timely original research across chemistry and its allied sciences. Free to readers and authors alike, original research content will be accompanied by additional editorial features. These additional editorial features include news stories contributed by the Society's award-winning science journalists, invited topical reviews (called Outlooks) from ...

Varied immunity by age 5 in children vaccinated with serogroup B meningococcus as babies

2015-03-23
Young children who received the 4CMenB vaccine as infants to protect against serogroup B meningococcal disease had waning immunity by age 5, even after receiving a booster at age 3 ½, according to new research in CMAJ (Canadian Medical Association Journal) Serogroup B meningococcal disease is the leading cause of meningitis and blood infections in developed countries. Infants and young children under the age of 5 years are especially at risk, and there is a second peak of cases in the late teenage years. The multicomponent serogroup B meningococcal (4CMenB) ...

Landmark study proves that magnets can control heat and sound

2015-03-23
COLUMBUS, Ohio--Researchers at The Ohio State University have discovered how to control heat with a magnetic field. In the March 23 issue of the journal Nature Materials, they describe how a magnetic field roughly the size of a medical MRI reduced the amount of heat flowing through a semiconductor by 12 percent. The study is the first ever to prove that acoustic phonons--the elemental particles that transmit both heat and sound--have magnetic properties. "This adds a new dimension to our understanding of acoustic waves," said Joseph Heremans, Ohio Eminent Scholar ...

Colliding stars explain enigmatic 17th century explosion

Colliding stars explain enigmatic 17th century explosion
2015-03-23
New observations made with APEX and other telescopes reveal that the star that European astronomers saw appear in the sky in 1670 was not a nova, but a much rarer, violent breed of stellar collision. It was spectacular enough to be easily seen with the naked eye during its first outburst, but the traces it left were so faint that very careful analysis using submillimetre telescopes was needed before the mystery could finally be unravelled more than 340 years later. The results appear online in the journal Nature on 23 March 2015. Some of seventeenth century's greatest ...

Combination therapy boosts antiviral response to chronic infection

2015-03-23
New Haven, Conn. -- A Yale-led team has identified a promising new combination immunotherapy to enhance the body's ability to fight chronic viral infections and possibly cancer. Their study was published March 23 in Nature Medicine. Viruses that cause chronic infection, such as HIV and Hepatitis B and C, are able to persist in the body despite attack from T cells, the body's main line of defense against pathogens. They persist because, over time, our T cells weaken to the point of "T-cell exhaustion." To circumvent this process, the research team -- led by Susan Kaech, ...

Policy makers should not discount the damages from future climate tipping points

2015-03-23
Society should set a high carbon tax now to try and prevent climate change reaching a point of no return according to a new study. The research, carried out by the Universities of Exeter, Zurich, Stanford and Chicago and published today in the journal Nature Climate Change shows that the prospect of an uncertain future tipping point should greatly increase the amount we are willing to pay now to limit climate change. Depending on the economic impacts of an abrupt change in climate and how quickly this is felt, the cost of carbon emitted now increases by 50 - 200%. Setting ...

Atlantic Ocean overturning found to slow down already today

Atlantic Ocean overturning found to slow down already today
2015-03-23
The gradual but accelerating melting of the Greenland ice-sheet, caused by man-made global warming, is a possible major contributor to the slowdown. Further weakening could impact marine ecosystems and sea level as well as weather systems in the US and Europe. "It is conspicuous that one specific area in the North Atlantic has been cooling in the past hundred years while the rest of the world heats up," says Stefan Rahmstorf of the Potsdam Institute for Climate Impact Research, lead author of the study to be published in Nature Climate Change. Previous research had already ...

Scientists use DNA sequencing to trace the spread of drug-resistant TB

2015-03-23
Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. Genetic analysis of the TB bacteria revealed how a 44-year-old man who died of the disease in 2012 caught the drug-resistant infection from a healthcare worker who had worked in South Africa, when both were admitted on the same medical ward four years earlier. TB is spread by inhaling tiny airborne droplets from an infected person. The bacteria can survive in the lungs for long periods without causing symptoms - known as latent ...

LAST 30 PRESS RELEASES:

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

[Press-News.org] Rett Syndrome Research Trust awards $1.3 million for clinical trial
Award to Case Western Reserve, Cleveland Clinic follows creation of regional collaborative to advance research